BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3064715)

  • 1. Treatment of reticulum cell sarcoma in SJL/J mice with Tween 80.
    Crispens CG; Sorenson JR
    Anticancer Res; 1988; 8(6):1341-3. PubMed ID: 3064715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of combinations of CuDIPS, Tween 80 and cyclophosphamide as therapy for reticulum cell sarcoma in SJL/J mice.
    Crispens CG; Sorenson JR
    Anticancer Res; 1989; 9(2):357-9. PubMed ID: 2665634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the anticancer activities of Tweens 20, 40 and 60 in SJL/J mice.
    Crispens CG; Sorenson JR
    Anticancer Res; 1991; 11(1):407-8. PubMed ID: 2018377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the anticancer activity of CuDIPS in SJL/J mice.
    Crispens CG; Sorenson JR
    Anticancer Res; 1988; 8(1):77-9. PubMed ID: 3358641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with CuDIPS, Tween 80 and cyclophosphamide: effects on survival and tumor incidence in SJL/J mice.
    Crispens CG; Sorenson JR
    In Vivo; 1990; 4(5):321-3. PubMed ID: 2133105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-gene abrogation of spontaneous pleomorphic SJL/J mouse reticulum cell sarcoma expression.
    Bubbers JE
    J Natl Cancer Inst; 1983 Oct; 71(4):795-9. PubMed ID: 6353030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-H-2-linked control of in vivo growth of SJL/J-derived reticulum cell sarcoma in recombinant inbred strains between BALB/cKe and SJL/J mice.
    Sakano T; Wilbur SM; Bonavida B; Cohn M
    J Natl Cancer Inst; 1985 Oct; 75(4):669-73. PubMed ID: 3900512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of reticulum cell sarcoma tumor growth in SJL/J mice by a serum inhibitor affecting T-cell proliferation.
    Sakano T; Wilbur SM; Bonavida B
    Cancer Res; 1985 Apr; 45(4):1573-8. PubMed ID: 3884142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of a transforming gene in spontaneous reticulum cell sarcoma of SJL/J mice: genetically linked and host-dependent neoplasia.
    Pulciani S; Sakano T; Ohnishi K; Anastasi AM; Pecorelli A; Fiorucci G; Oppi C; Rossi GB; Bonavida B
    Cancer Res; 1987 Jan; 47(2):523-6. PubMed ID: 3539324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hodgkin's-like reticulum cell sarcoma in SJL-J mouse. An animal model of lymphoma to solve clinical problems.
    Rubin P
    Radiol Clin North Am; 1968 Apr; 6(1):25-44. PubMed ID: 4871075
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on leukemia development in the SJL/J strain of mice.
    Haran-Ghera N; Kotler M; Meshorer A
    J Natl Cancer Inst; 1967 Oct; 39(4):653-61. PubMed ID: 18623927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application-dependent immunomodulating and antimetastatic efficacy of thymic peptides in BALB/c-mice.
    Beuth J; Schierholz JM; Ko HL; Braun JM
    In Vivo; 2001; 15(5):403-6. PubMed ID: 11695237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variance contributes to naltrexone-induced inhibition of sucrose intake in inbred and outbred mouse strains.
    Dym CT; Pinhas A; Ginzberg M; Kest B; Bodnar RJ
    Brain Res; 2007 Mar; 1135(1):136-45. PubMed ID: 17204254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 1, 3-diallylurea and related compounds on growth of transplanted animal tumors.
    Tarnowski GS; Cappuccino JG; Schmid FA
    Cancer Res; 1967 Jun; 27(6):1092-5. PubMed ID: 5229785
    [No Abstract]   [Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of surfactant concentration on the antitumor activity of emulsified components of mycobacteria.
    Yarkoni E; Rapp HJ
    Cancer Res; 1980 Apr; 40(4):975-8. PubMed ID: 7357563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further studies on the tumor inhibitory effects of carbobenzoxy derivatives of amino acids.
    Shohat B; Schlesinger M; Grossowicz N; Lichtenstein N
    Isr J Med Sci; 1972 Jan; 8(1):29-33. PubMed ID: 5067528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.